The safety profile of drug treatment of alzheimer's disease
Despite the fact that Alzheimer's disease is being intensively studied for many years, its main etiopathogenic mechanisms are still unknown. At the same time, given the prognosis of the disease and its prevalence, the problem of adequate medical treatment is an important medical and social prob...
Saved in:
| Main Author: | V. А. Moroz |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Zaporizhzhia State Medical and Pharmaceutical University
2013-06-01
|
| Series: | Zaporožskij Medicinskij Žurnal |
| Subjects: | |
| Online Access: | http://zmj.zsmu.edu.ua/article/view/13572/11931 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Polypragmasy at treatment of <i>H. pylori</i> infection in patients with concomitant diseases of other organs and systems. How to prevent side effects related to drug interactions?
by: S. G. Burkov, et al.
Published: (2011-05-01) -
Medication reconciliation role and value in Alzheimer's disease treatment
by: Xueqian Shen, et al.
Published: (2022-02-01) -
Prospecting Marine Natural Products as the Disease-Modifying Treatment of Alzheimer’s Diseases
by: Legis Ocktaviana Saputri, et al.
Published: (2024-10-01) -
Pathological mechanisms and treatment progression of Alzheimer’s disease
by: Jingjing Zhang, et al.
Published: (2025-07-01) -
Brain‐derived tau to measure treatment effect in Alzheimer's disease and frontotemporal dementia
by: Cassandra Marotta, et al.
Published: (2025-04-01)